| Net Cash Provided by (Used in) Operating Activities |
$819,488 |
USD |
-60% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,435,116 |
USD |
20% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
1,534,942 |
shares |
-9.3% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$615,628 |
USD |
-337% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,089,063 |
USD |
-56% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$298,830 |
USD |
-21% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$20,938,943 |
USD |
-7% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$2,003,638 |
USD |
14% |
Q1 2024 |
Q1 2024 |